Clinical Report: Models for Predicting Sepsis-Related Lung Injury and Mortality
Overview
This comprehensive review and meta-analysis evaluated models predicting sepsis-related lung injury and mortality. Findings indicate moderate discrimination in current models, but limitations due to bias, weak methods, and low certainty of evidence were noted.
Background
Sepsis is a significant global health issue, affecting over 19 million individuals annually and leading to high mortality rates. The lungs are often among the first organs affected, with sepsis-related lung injury, including ARDS, contributing to poor outcomes. Understanding predictive models for these complications is crucial for improving patient management and outcomes.
Data Highlights
Outcome
Pooled AUC
95% CI
I²
ARDS occurrence (test phase)
0.749
0.648–0.849
98.9%
Short-term mortality (training)
0.800
0.761–0.838
97.9%
Short-term mortality (validation)
0.778
0.751–0.804
63.5%
Short-term mortality (testing)
0.815
0.780–0.850
75.7%
Key Findings
Moderate discrimination was observed in models predicting ARDS occurrence and short-term mortality.
High risk of bias was noted in 4 out of 9 studies assessed.
Machine learning models did not consistently outperform traditional logistic regression models.
Heterogeneity was high, particularly for ARDS occurrence and mortality training models.
Certainty of evidence was low across all outcome families and modeling phases.
Clinical Implications
The findings highlight the need for improved predictive models for sepsis-related lung injury and mortality. Clinicians should be aware of the limitations of current models due to bias and low certainty of evidence when making clinical decisions.
Conclusion
Current predictive models for sepsis-related lung injury and mortality demonstrate moderate discrimination but are limited by methodological weaknesses. Future research should focus on transparent designs and external validation.
